Advertisement
The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

Pharmaceutical, Biotech Mergers Set Record in 2014

March 19, 2015 1:42 pm | by Andy Szal, Digital Reporter | News | Comments

Mergers and acquisitions in the pharmaceutical and biotechnology sectors set a record in 2014, according to a report by Evaluate Ltd.

TOPICS:

Analyst: Big Pharma Should Increase Investments in Alzheimer’s, Parkinson’s

March 19, 2015 10:14 am | by Andy Szal, Digital Reporter | News | Comments

Improved coordination between researchers and pharmaceutical companies could help bolster development of treatments for neurodegenerative diseases such as Alzheimer's or Parkinson's, according to an industry analyst.

TOPICS:

Boehner, Pelosi See Victories in Fixing Medicare Doctors' Fees

March 19, 2015 8:42 am | by ALAN FRAM, Associated Press | News | Comments

An uncharacteristic joint effort by House Speaker John Boehner and his usual nemesis, Minority Leader Nancy Pelosi, to resolve a gnawing problem about how Medicare pays doctors underscores the political victories each sees in finally sweeping the issue off the deck — if they can.

TOPICS:
Advertisement

Study: Prevnar Vaccine Slashed Serious Infections in Elderly

March 19, 2015 8:33 am | by LINDA A. JOHNSON, AP Business Writer | News | Comments

A huge study of Pfizer's blockbuster vaccine against pneumonia and other bacterial infections in adults 65 and older found it protected most of them against dangerous infections in the bloodstream and other sterile body areas.

TOPICS:

Daiichi Sankyo Signs Agreement with AstraZeneca to Co-Commercialize MOVANTIK in the US

March 19, 2015 8:18 am | News | Comments

Under the terms of the agreement, Daiichi Sankyo will pay a $200M up-front fee and subsequent sales-related payments of up to $625M. AstraZeneca will be responsible for manufacturing, will book all sales and will make sales-related commission payments to Daiichi Sankyo.

TOPICS:

Report: U.S. Market for Asthma Treatment to See Modest Growth

March 19, 2015 8:09 am | by Andy Szal, Digital Reporter | News | Comments

The analysis by New York-based GBI Research predicted the recent expiration of patents for several of the top current therapeutics--most notably Singulair, Advair and Symbicort--would allow generic versions to curb market growth.

TOPICS:

Poll: Many Unaware Some Health Subsidies Could Be Ruled Out

March 19, 2015 8:01 am | by RICARDO ALONSO-ZALDIVAR, Associated Press | News | Comments

With a decision due by summer in a Supreme Court case that could unravel President Barack Obama's health care law, a new poll finds many Americans have heard nothing about the case. But when the potential fallout is explained, most say it would hurt the country and they would look to Congress or the states to fix it.

TOPICS:

Herbalife Pyramid-Scheme Suit Dismissed

March 18, 2015 4:12 pm | News | Comments

A judge has dismissed a lawsuit by Herbalife shareholders who claimed that the business structure and marketing practices of the weight loss and nutritional supplements company violated the law and that they lost money in what amounts to a pyramid scheme.

TOPICS:
Advertisement

Volumetric Glassware

March 18, 2015 4:12 pm | by Poulten & Graf Ltd | Product Releases | Comments

Poulten & Graf offer a wide range of volumetric glassware under the VOLAC and FORTUNA® brands. All Volumetric Glassware is made according to ASTM, USP, and ISO standards. Certification is available, either as a batch or individually, with appropriate ring marks. Calibration of flasks and cylinders is "IN"; indicating that the liquid poured out equals the volume indicated.

Vertex Gets FDA Approval of KALYDECO® for Children with Cystic Fibrosis

March 18, 2015 3:54 pm | News | Comments

Vertex Pharmaceuticals has announced that the FDA approved KALYDECO® for use in children ages 2 to 5 with cystic fibrosis (CF) who have one of 10 mutations in the cystic fibrosis transmembrane conductance regulator ( CFTR) gene.

TOPICS:

Chemical Regulation Overhaul Bill Faces Opposition in Senate

March 18, 2015 3:47 pm | by MATTHEW DALY, Associated Press | News | Comments

A bipartisan bill that would update regulation of harmful chemicals for the first time in nearly 40 years is drawing opposition from some Democrats and environmental groups, who charged on Wednesday that the measure is a step backward in protecting health and the environment.

TOPICS:

AbbVie and Puerto Rico Announce $30M Expansion

March 18, 2015 1:40 pm | News | Comments

Puerto Rico and AbbVie announced today the expansion of one of AbbVie’s existing sites in the island with an estimated investment of $30M. This expansion will add to Puerto Rico’s capabilities as a manufacturing destination for biotechnology and is expected to create up to 100 new jobs over the next two years.

TOPICS:

New Cholesterol Drug Could Be Biggest Advance Since Statins

March 18, 2015 8:21 am | News | Comments

Studies show the new drug slashes bad cholesterol, or "LDL," by up to 61% and cuts heart attacks and strokes by more than half.

TOPICS:

House Leaders Work on $213B Plan on Doctor Medicare Payments

March 18, 2015 8:08 am | by ALAN FRAM, Associated Press; ANDREW TAYLOR, Associated Press | News | Comments

Bipartisan House leaders are working on a $213 billion plan to permanently change how doctors are paid for treating Medicare patients, a costly problem that's vexed Congress for years, a document circulating among lawmakers showed Tuesday.

TOPICS:

Equatorial Guinea Holds Malaria Vaccine Trial

March 18, 2015 8:03 am | News | Comments

Equatorial Guinea has held the first clinical trial of a new malaria vaccine known as PfSPZ. Three volunteers participated this month in the trial of the vaccine, which was developed by the American biotechnology company Sanaria.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading